Trial
NCT04200352
A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators
—
Condition
Cerebral Palsy, Dyskinetic
Intervention
TEV-50717
Why stopped
Failure of TV50717-CNS-30080 (parent study) to meet the primary efficacy endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-22